These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

900 related articles for article (PubMed ID: 17514407)

  • 21. Axillary Lymph Node Ultrasound Following Neoadjuvant Chemotherapy in Biopsy-Proven Node-Positive Breast Cancer: Results from the SN FNAC Study.
    Morency D; Dumitra S; Parvez E; Martel K; Basik M; Robidoux A; Poirier B; Holloway CMB; Gaboury L; Sideris L; Meterissian S; Boileau JF
    Ann Surg Oncol; 2019 Dec; 26(13):4337-4345. PubMed ID: 31605348
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role for sentinel lymph node dissection after neoadjuvant chemotherapy in patients who present with node-positive breast cancer.
    Alvarado R; Yi M; Le-Petross H; Gilcrease M; Mittendorf EA; Bedrosian I; Hwang RF; Caudle AS; Babiera GV; Akins JS; Kuerer HM; Hunt KK
    Ann Surg Oncol; 2012 Oct; 19(10):3177-84. PubMed ID: 22772869
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Clinical usefulness and perspectives of sentinel node biopsy in the management of breast cancer].
    Haid A; Koeberle-Wuehrer R; Offner F; Jasarevic Z; Fritzsche H; Zimmermann G
    Chirurg; 2003 Jul; 74(7):657-64. PubMed ID: 12883794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clipped Axillary Node as a Potential Surrogate for Overall Axillary Nodal Status in Inflammatory Breast Cancer Patients after Neoadjuvant Chemotherapy.
    Lohani KR; Hoskin TL; Yasir S; Olson CA; Boughey JC; Hieken TJ; Degnim AC
    Ann Surg Oncol; 2024 Oct; 31(11):7431-7440. PubMed ID: 39120840
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sentinel node biopsy and neoadjuvant chemotherapy in the treatment of breast cancer.
    Gatek J; Vrana D; Hnatek L; Bakala J; Dudesek B; Duben J; Musil T
    J BUON; 2012; 17(2):265-70. PubMed ID: 22740204
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sentinel lymph node mapping following neoadjuvant chemotherapy for breast cancer.
    Brady EW
    Breast J; 2002; 8(2):97-100. PubMed ID: 11896755
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Axillary Staging After Neoadjuvant Chemotherapy for Breast Cancer: A Pilot Study Combining Sentinel Lymph Node Biopsy with Radioactive Seed Localization of Pre-treatment Positive Axillary Lymph Nodes.
    Diego EJ; McAuliffe PF; Soran A; McGuire KP; Johnson RR; Bonaventura M; Ahrendt GM
    Ann Surg Oncol; 2016 May; 23(5):1549-53. PubMed ID: 26727919
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Imaging response and residual metastatic axillary lymph node disease after neoadjuvant chemotherapy for primary breast cancer.
    Hieken TJ; Boughey JC; Jones KN; Shah SS; Glazebrook KN
    Ann Surg Oncol; 2013 Oct; 20(10):3199-204. PubMed ID: 23846781
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative).
    Ollila DW; Cirrincione CT; Berry DA; Carey LA; Sikov WM; Hudis CA; Winer EP; Golshan M
    J Am Coll Surg; 2017 Apr; 224(4):688-694. PubMed ID: 28089784
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Axillary staging prior to neoadjuvant chemotherapy for breast cancer: predictors of recurrence.
    Kilbride KE; Lee MC; Nees AV; Cimmino VM; Diehl KM; Sabel MS; Hayes DF; Schott AF; Kleer CG; Chang AE; Newman LA
    Ann Surg Oncol; 2008 Nov; 15(11):3252-8. PubMed ID: 18784961
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Improved False-Negative Rates with Intraoperative Identification of Clipped Nodes in Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy.
    Cabıoğlu N; Karanlık H; Kangal D; Özkurt E; Öner G; Sezen F; Yılmaz R; Tükenmez M; Önder S; İğci A; Özmen V; Dinççağ A; Engin G; Müslümanoğlu M
    Ann Surg Oncol; 2018 Oct; 25(10):3030-3036. PubMed ID: 29978371
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relationship of clinical and pathologic response to neoadjuvant chemotherapy and outcome of locally advanced breast cancer.
    Gajdos C; Tartter PI; Estabrook A; Gistrak MA; Jaffer S; Bleiweiss IJ
    J Surg Oncol; 2002 May; 80(1):4-11. PubMed ID: 11967899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Surgical Management of the Axilla in Clinically Node-Positive Patients Receiving Neoadjuvant Chemotherapy: A National Cancer Database Analysis.
    Wong SM; Weiss A; Mittendorf EA; King TA; Golshan M
    Ann Surg Oncol; 2019 Oct; 26(11):3517-3525. PubMed ID: 31342389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sentinel node biopsy after neoadjuvant chemotherapy in cytologically proven node-positive breast cancer.
    Yagata H; Yamauchi H; Tsugawa K; Hayashi N; Yoshida A; Kajiura Y; In R; Matsuda N; Nakamura S
    Clin Breast Cancer; 2013 Dec; 13(6):471-7. PubMed ID: 24267732
    [TBL] [Abstract][Full Text] [Related]  

  • 35. De-escalation of axillary surgery in breast cancer patients treated in the neoadjuvant setting: a Dutch population-based study.
    Simons JM; Koppert LB; Luiten EJT; van der Pol CC; Samiei S; de Wilt JHW; Siesling S; Smidt ML
    Breast Cancer Res Treat; 2020 Apr; 180(3):725-733. PubMed ID: 32180074
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is Nodal Clipping Beneficial for Node-Positive Breast Cancer Patients Receiving Neoadjuvant Chemotherapy?
    Montagna G; Lee MK; Sevilimedu V; Barrio AV; Morrow M
    Ann Surg Oncol; 2022 Oct; 29(10):6133-6139. PubMed ID: 35902495
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sentinel lymph node biopsy after neoadjuvant chemotherapy is accurate in breast cancer patients with a clinically negative axillary nodal status at presentation.
    Gimbergues P; Abrial C; Durando X; Le Bouedec G; Cachin F; Penault-Llorca F; Mouret-Reynier MA; Kwiatkowski F; Maublant J; Tchirkov A; Dauplat J
    Ann Surg Oncol; 2008 May; 15(5):1316-21. PubMed ID: 18311507
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of axillary response by monitoring with ultrasound and MRI during and after neoadjuvant chemotherapy in breast cancer patients.
    Eun NL; Son EJ; Gweon HM; Kim JA; Youk JH
    Eur Radiol; 2020 Mar; 30(3):1460-1469. PubMed ID: 31802216
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sentinel lymph node biopsy after neoadjuvant chemotherapy in a patient with operable breast cancer.
    Hino M; Sano M; Sato N; Homma K
    Surg Today; 2008; 38(7):585-91. PubMed ID: 18612781
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selection of local therapy after neoadjuvant chemotherapy in patients with stage IIIA,B breast cancer.
    Danforth DN; Zujewski J; O'Shaughnessy J; Riseberg D; Steinberg SM; McAtee N; Noone M; Chow C; Chaudhry U; Lippman M; Jacobson J; Okunieff P; Cowan KH
    Ann Surg Oncol; 1998 Mar; 5(2):150-8. PubMed ID: 9527268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 45.